Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 218

1.

Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential.

McClung MR.

Ther Adv Musculoskelet Dis. 2017 Oct;9(10):263-270. doi: 10.1177/1759720X17726744. Epub 2017 Aug 29. Review.

2.

Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.

McClung MR, Lippuner K, Brandi ML, Zanchetta JR, Bone HG, Chapurlat R, Hans D, Wang A, Zapalowski C, Libanati C.

Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4140-y. [Epub ahead of print]

PMID:
28748386
3.

Using Osteoporosis Therapies in Combination.

McClung MR.

Curr Osteoporos Rep. 2017 Aug;15(4):343-352. doi: 10.1007/s11914-017-0376-x. Review.

PMID:
28667435
4.

Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies.

Hanley DA, McClung MR, Davison KS, Dian L, Harris ST, Miller PD, Lewiecki EM, Kendler DL; Writing Group for the Western Osteoporosis Alliance.

Am J Med. 2017 Jul;130(7):862.e1-862.e7. doi: 10.1016/j.amjmed.2017.03.002. Epub 2017 Mar 27. Review.

PMID:
28359721
5.

An update on osteoporosis pathogenesis, diagnosis, and treatment.

McClung M, Baron R, Bouxsein M.

Bone. 2017 May;98:37. doi: 10.1016/j.bone.2017.02.013. Epub 2017 Mar 2. No abstract available.

PMID:
28263916
6.

Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases.

Lewiecki EM, Bilezikian JP, Bukata SV, Camacho P, Clarke BL, McClung MR, Miller PD, Shepherd J.

J Clin Densitom. 2017 Apr - Jun;20(2):134-152. doi: 10.1016/j.jocd.2017.01.001. Epub 2017 Feb 6. Review.

7.

Observations following discontinuation of long-term denosumab therapy.

McClung MR, Wagman RB, Miller PD, Wang A, Lewiecki EM.

Osteoporos Int. 2017 May;28(5):1723-1732. doi: 10.1007/s00198-017-3919-1. Epub 2017 Jan 31.

8.

Clinical utility of anti-sclerostin antibodies.

McClung MR.

Bone. 2017 Mar;96:3-7. doi: 10.1016/j.bone.2016.12.012. Epub 2017 Jan 20.

PMID:
28115281
9.

Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis.

Zebaze R, Libanati C, McClung MR, Zanchetta JR, Kendler DL, Høiseth A, Wang A, Ghasem-Zadeh A, Seeman E.

J Bone Miner Res. 2016 Oct;31(10):1827-1834. doi: 10.1002/jbmr.2855. Epub 2016 May 19.

10.

The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.

Chakhtoura M, Leslie WD, McClung M, Cheung AM, Fuleihan GE.

Osteoporos Int. 2017 Jan;28(1):127-137. doi: 10.1007/s00198-016-3766-5. Epub 2016 Sep 20.

PMID:
27650643
11.

RE-INVIGORATING THE OSTEOPOROSIS MESSAGE.

McClung MR.

Endocr Pract. 2016 Sep;22(9):1130-1. doi: 10.4158/EP161533.CO. No abstract available.

PMID:
27643924
12.

REINVIGORATING THE OSTEOPOROSIS MESSAGE.

McClung MR.

Endocr Pract. 2016 Sep 15. [Epub ahead of print] No abstract available.

PMID:
27631671
13.

Cancel the denosumab holiday.

McClung MR.

Osteoporos Int. 2016 May;27(5):1677-82. doi: 10.1007/s00198-016-3553-3. Epub 2016 Mar 1. No abstract available.

PMID:
26932443
14.

Using a Handheld Device for Patient Data Collection: A Pilot for Medical Countermeasures Surveillance.

Daley MF, Goddard K, McClung M, Davidson A, Weiss G, Palen T, Nyirenda C, Platt R, Courtney B, Reichman ME.

Public Health Rep. 2016 Jan-Feb;131(1):30-4.

15.

Bone Mineral Density and Parathyroid Hormone as Independent Risk Factors for Mortality in Community-Dwelling Older Adults: A Population-Based Prospective Cohort Study in Brazil. The São Paulo Ageing & Health (SPAH) Study.

Domiciano DS, Machado LG, Lopes JB, Figueiredo CP, Caparbo VF, Oliveira RM, Scazufca M, McClung MR, Pereira RM.

J Bone Miner Res. 2016 Jun;31(6):1146-57. doi: 10.1002/jbmr.2795. Epub 2016 Mar 5.

16.

Proceedings of the 2015 Santa Fe Bone Symposium: Clinical Applications of Scientific Advances in Osteoporosis and Metabolic Bone Disease.

Lewiecki EM, Baron R, Bilezikian JP, Gagel RE, Leonard MB, Leslie WD, McClung MR, Miller PD.

J Clin Densitom. 2016 Jan-Mar;19(1):102-16. doi: 10.1016/j.jocd.2015.11.003. Epub 2015 Dec 29.

PMID:
26750746
17.

A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates.

Cosman F, Gilchrist N, McClung M, Foldes J, de Villiers T, Santora A, Leung A, Samanta S, Heyden N, McGinnis JP 2nd, Rosenberg E, Denker AE.

Osteoporos Int. 2016 Jan;27(1):377-86. doi: 10.1007/s00198-015-3392-7. Epub 2015 Nov 10.

PMID:
26556736
18.

Vertebral Fractures: Clinical Importance and Management.

Kendler DL, Bauer DC, Davison KS, Dian L, Hanley DA, Harris ST, McClung MR, Miller PD, Schousboe JT, Yuen CK, Lewiecki EM.

Am J Med. 2016 Feb;129(2):221.e1-10. doi: 10.1016/j.amjmed.2015.09.020. Epub 2015 Oct 30. Review.

PMID:
26524708
19.

New management options for osteoporosis with emphasis on SERMs.

McClung MR.

Climacteric. 2015;18 Suppl 2:56-61. doi: 10.3109/13697137.2015.1104010. Epub 2015 Oct 27. Review.

PMID:
26503459
20.

Late skeletal effects of early menopause.

McClung MR.

Menopause. 2015 Oct;22(10):1027-9. doi: 10.1097/GME.0000000000000537. No abstract available.

PMID:
26397143

Supplemental Content

Loading ...
Support Center